|
Nathan
S. Arenson Fund for Pancreatic Cancer Research
Benefits
the and the work of Dr. Olivera
Finn Ph.D. Dr. Finn, Director of UPCI’s Immunology Program
has developed a program which tests a new vaccine that may prove
to be an effective treatment for pancreatic cancer.
Dr. Finn has been a member of UPCI’s cancer research team
since 1985 and was granted clinical approval for the vaccine program
in August of 1998. The vaccine was funded by the Nathan S. Arenson
Fund.
More importantly, patients who have been newly diagnosed with
the disease are receiving this vaccine. In addition, patients
receiving the vaccine have not received any other treatment that
might weaken their immune system. The desired outcome is that
the cancer will stop spreading and the vaccine will significantly
prolong their lives. The trial is expected to recruit 20 patients
at $10,000 per patient which the Nathan S. Arenson Fund sponsors.
Donations
may be made to: Arenson Fund/UPCI
Donations
may be mailed to: Dr. Olivera Finn
UPCI - Molecular Genetics
Bio Medical Science Center
W-1142 School of Medicine
Pittsburgh, PA 15261
412-429-1375
|
